关于口服避孕药和非处方获取的知识差距、信息需求和偏好：一项针对出生时被指定为女性的黑人和拉丁裔年轻人的焦点小组研究。

IF 2.8 2区医学 Q1 OBSTETRICS & GYNECOLOGY

Contraception Pub Date : 2025-04-09 DOI:10.1016/j.contraception.2025.110900

Riley J. Steiner , Sarah M. Axelson , Claudia Nuñez-Eddy , Kelsie Williams , Robin Watkins , Tiffany Lloyd , Francisco Zamudio

{"title":"关于口服避孕药和非处方获取的知识差距、信息需求和偏好：一项针对出生时被指定为女性的黑人和拉丁裔年轻人的焦点小组研究。","authors":"Riley J. Steiner , Sarah M. Axelson , Claudia Nuñez-Eddy , Kelsie Williams , Robin Watkins , Tiffany Lloyd , Francisco Zamudio","doi":"10.1016/j.contraception.2025.110900","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>On July 13, 2023, the Food and Drug Administration (FDA) approved a progestin-only oral contraceptive pill (OCP) for over-the-counter (OTC) use without an age restriction. Prior to this approval, we launched a qualitative study with Black and Latinx young people to inform access to an OTC OCP. Here we present findings related to knowledge gaps and information needs and preferences.</div></div><div><h3>Study design</h3><div>From April 26 to July 27, 2023, we held eight in-person focus groups (prior to the FDA approval) and one virtual focus group (after the FDA approval) with 65 pregnancy-capable young people aged 15–24 years (median 18 years) who identified as Black and/or Latinx. Community partners in Los Angeles, CA, Syracuse, NY, and Jackson, MS recruited participants from youth-serving programs and via social media. Authors double-coded focus group transcripts and analyzed the data thematically.</div></div><div><h3>Results</h3><div>Participants largely did not know that an OTC OCP was possible. Many participants wanted to learn about an OTC OCP from health care providers and consult with a provider for follow-up as needed. Participants wanted to know about effectiveness and side effects, including at point-of-sale. Some participants had misconceptions about the safety of OCPs in general.</div></div><div><h3>Conclusions</h3><div>Findings suggest that Black and Latinx young people want information about an OTC OCP from providers. Providers can help support equitable access to an OTC OCP by educating young people about OTC availability and the safety and effectiveness of this option regardless of cost or location. Such education can address broader misconceptions about OCPs.</div></div><div><h3>Implications</h3><div>Results can inform efforts to increase awareness of an OTC OCP among Black and Latinx young people. Health care providers should provide information about effectiveness and side effects of this option.</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"147 ","pages":"Article 110900"},"PeriodicalIF":2.8000,"publicationDate":"2025-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Knowledge gaps and information needs and preferences regarding oral contraceptive pills and over-the-counter access: A focus group study with Black and Latinx young people assigned female at birth\",\"authors\":\"Riley J. Steiner , Sarah M. Axelson , Claudia Nuñez-Eddy , Kelsie Williams , Robin Watkins , Tiffany Lloyd , Francisco Zamudio\",\"doi\":\"10.1016/j.contraception.2025.110900\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>On July 13, 2023, the Food and Drug Administration (FDA) approved a progestin-only oral contraceptive pill (OCP) for over-the-counter (OTC) use without an age restriction. Prior to this approval, we launched a qualitative study with Black and Latinx young people to inform access to an OTC OCP. Here we present findings related to knowledge gaps and information needs and preferences.</div></div><div><h3>Study design</h3><div>From April 26 to July 27, 2023, we held eight in-person focus groups (prior to the FDA approval) and one virtual focus group (after the FDA approval) with 65 pregnancy-capable young people aged 15–24 years (median 18 years) who identified as Black and/or Latinx. Community partners in Los Angeles, CA, Syracuse, NY, and Jackson, MS recruited participants from youth-serving programs and via social media. Authors double-coded focus group transcripts and analyzed the data thematically.</div></div><div><h3>Results</h3><div>Participants largely did not know that an OTC OCP was possible. Many participants wanted to learn about an OTC OCP from health care providers and consult with a provider for follow-up as needed. Participants wanted to know about effectiveness and side effects, including at point-of-sale. Some participants had misconceptions about the safety of OCPs in general.</div></div><div><h3>Conclusions</h3><div>Findings suggest that Black and Latinx young people want information about an OTC OCP from providers. Providers can help support equitable access to an OTC OCP by educating young people about OTC availability and the safety and effectiveness of this option regardless of cost or location. Such education can address broader misconceptions about OCPs.</div></div><div><h3>Implications</h3><div>Results can inform efforts to increase awareness of an OTC OCP among Black and Latinx young people. Health care providers should provide information about effectiveness and side effects of this option.</div></div>\",\"PeriodicalId\":10762,\"journal\":{\"name\":\"Contraception\",\"volume\":\"147 \",\"pages\":\"Article 110900\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-04-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Contraception\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0010782425000915\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contraception","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0010782425000915","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

目的：2023年7月13日，美国食品和药物管理局（FDA）批准了一种无年龄限制的纯孕激素口服避孕药（OCP）作为非处方药（OTC）使用。在此批准之前，我们在黑人和拉丁裔年轻人中开展了一项定性研究，以了解OTC OCP的获取情况。在这里，我们提出了与知识差距和信息需求和偏好相关的研究结果。研究设计：从2023年4月26日到7月27日，我们举行了8个面对面的焦点小组（FDA批准之前）和一个虚拟焦点小组（FDA批准之后），其中65名年龄在15-24岁（中位数为18岁）的有怀孕能力的年轻人，他们被认为是黑人和/或拉丁裔。加州洛杉矶、纽约州锡拉丘兹和密西西比州杰克逊的社区合作伙伴从青年服务项目和社交媒体中招募了参与者。作者对焦点小组记录进行了双重编码，并对数据进行了主题分析。结果：参与者大多不知道OTC OCP是可能的。许多参与者希望从卫生保健提供者那里了解OTC OCP，并根据需要咨询提供者进行随访。参与者想知道药物的有效性和副作用，包括在销售点。一些与会者对ocp的安全性普遍存在误解。结论：研究结果表明，黑人和拉丁裔年轻人希望从供应商那里获得有关OTC OCP的信息。提供者可以通过教育年轻人了解OTC的可获得性以及这种选择的安全性和有效性，无论成本或地点如何，帮助支持公平获得OTC OCP。这样的教育可以消除对ocp更广泛的误解。意义：结果可以告知努力提高黑人和拉丁裔年轻人对OTC OCP的认识。医疗保健提供者应提供有关该选择的有效性和副作用的信息。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Knowledge gaps and information needs and preferences regarding oral contraceptive pills and over-the-counter access: A focus group study with Black and Latinx young people assigned female at birth

Objective

On July 13, 2023, the Food and Drug Administration (FDA) approved a progestin-only oral contraceptive pill (OCP) for over-the-counter (OTC) use without an age restriction. Prior to this approval, we launched a qualitative study with Black and Latinx young people to inform access to an OTC OCP. Here we present findings related to knowledge gaps and information needs and preferences.

Study design

From April 26 to July 27, 2023, we held eight in-person focus groups (prior to the FDA approval) and one virtual focus group (after the FDA approval) with 65 pregnancy-capable young people aged 15–24 years (median 18 years) who identified as Black and/or Latinx. Community partners in Los Angeles, CA, Syracuse, NY, and Jackson, MS recruited participants from youth-serving programs and via social media. Authors double-coded focus group transcripts and analyzed the data thematically.

Results

Participants largely did not know that an OTC OCP was possible. Many participants wanted to learn about an OTC OCP from health care providers and consult with a provider for follow-up as needed. Participants wanted to know about effectiveness and side effects, including at point-of-sale. Some participants had misconceptions about the safety of OCPs in general.

Conclusions

Findings suggest that Black and Latinx young people want information about an OTC OCP from providers. Providers can help support equitable access to an OTC OCP by educating young people about OTC availability and the safety and effectiveness of this option regardless of cost or location. Such education can address broader misconceptions about OCPs.

Implications

Results can inform efforts to increase awareness of an OTC OCP among Black and Latinx young people. Health care providers should provide information about effectiveness and side effects of this option.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Contraception 医学-妇产科学

CiteScore

4.70

自引率

17.20%

发文量

211

审稿时长

69 days

期刊介绍： Contraception has an open access mirror journal Contraception: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. The journal Contraception wishes to advance reproductive health through the rapid publication of the best and most interesting new scholarship regarding contraception and related fields such as abortion. The journal welcomes manuscripts from investigators working in the laboratory, clinical and social sciences, as well as public health and health professions education.